Publicaciones (298) Publicaciones de Jesús Fortun Abete

2024

  1. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis

    Journal of Fungi, Vol. 10, Núm. 3

  2. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK

    Journal of Hospital Infection, Vol. 147, pp. 123-132

  3. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials

    The Lancet Infectious Diseases, Vol. 24, Núm. 3, pp. 319-328

  4. Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 2

  5. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology

  6. Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology spectrum, Vol. 12, Núm. 1, pp. e0206423

  7. Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology Spectrum, Vol. 12, Núm. 2

  8. Using staged tree models for health data: Investigating invasive fungal infections by aspergillus and other filamentous fungi

    Computational and Structural Biotechnology Journal, Vol. 24, pp. 12-22

2023

  1. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    Journal of Infection, Vol. 87, Núm. 1, pp. 46-53

  2. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis

    Critical Care, Vol. 27, Núm. 1

  3. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  4. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

    Journal of Fungi, Vol. 9, Núm. 6

  5. Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection

    Journal of Fungi, Vol. 9, Núm. 2

  6. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

  7. Recommendations on the use of azole antifungals in hematology-oncology patients

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 3, pp. 236-258

  8. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    The Lancet, Vol. 401, Núm. 10370, pp. 49-59

  9. Staphylococcus aureus surgical site infection rates in 5 European countries

    Antimicrobial Resistance and Infection Control, Vol. 12, Núm. 1

2022

  1. Antibiotic stability in portable elastomeric infusion devices: A systematic review

    American Journal of Health-System Pharmacy, Vol. 79, Núm. 16, pp. 1355-1368

  2. Carbapenemase-producing Enterobacterales infections in COVID-19 patients

    Infectious Diseases, Vol. 54, Núm. 1, pp. 36-45

  3. Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient

    Revista Espanola de Quimioterapia, Vol. 35, pp. 97-103